Serum immunoglobulins are an independent prognostic marker of time to first therapy in newly diagnosed chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL)

Sameer A Parikh; Cristine Allmer; Geffen Kleinstern; Nicholas J Boddicker; Shulan Tian; Cecilia B De Campos; Laura A Bruins; Brian F Kabat; Kari G Rabe; Aaron D Norman

doi:10.1158/1538-7445.AM2020-6466

Serum immunoglobulins are an independent prognostic marker of time to first therapy in newly diagnosed chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL)

Sameer A Parikh
, Cristine Allmer
, Geffen Kleinstern
, Nicholas J Boddicker
, Shulan Tian
, Cecilia B De Campos
, Laura A Bruins
, Brian F Kabat
, Kari G Rabe
, Aaron D Norman

School of Public Health

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	Abstract 6466
Pages (from-to)	6466
Number of pages	1
Journal	Cancer Research
Volume	80
Issue number	supp 16
DOIs	https://doi.org/10.1158/1538-7445.AM2020-6466
State	Published - 2020
Event	AACR Annual Meeting - Philadelphia, United States Duration: 27 Apr 2020 → 24 Jun 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1158/1538-7445.AM2020-6466

Cite this

Parikh, S. A., Allmer, C., Kleinstern, G., Boddicker, N. J., Tian, S., De Campos, C. B., Bruins, L. A., Kabat, B. F., Rabe, K. G., & Norman, A. D. (2020). Serum immunoglobulins are an independent prognostic marker of time to first therapy in newly diagnosed chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL). Cancer Research, 80(supp 16), 6466. Article Abstract 6466. https://doi.org/10.1158/1538-7445.AM2020-6466

@article{84c0b02706664e95a82a00adf83b80f2,

title = "Serum immunoglobulins are an independent prognostic marker of time to first therapy in newly diagnosed chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL)",

author = "Parikh, \{Sameer A\} and Cristine Allmer and Geffen Kleinstern and Boddicker, \{Nicholas J\} and Shulan Tian and \{De Campos\}, \{Cecilia B\} and Bruins, \{Laura A\} and Kabat, \{Brian F\} and Rabe, \{Kari G\} and Norman, \{Aaron D\}",

year = "2020",

doi = "10.1158/1538-7445.AM2020-6466",

language = "English",

volume = "80",

pages = "6466",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "supp 16",

note = "AACR Annual Meeting ; Conference date: 27-04-2020 Through 24-06-2020",

}

Parikh, SA, Allmer, C, Kleinstern, G, Boddicker, NJ, Tian, S, De Campos, CB, Bruins, LA, Kabat, BF, Rabe, KG & Norman, AD 2020, 'Serum immunoglobulins are an independent prognostic marker of time to first therapy in newly diagnosed chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL)', Cancer Research, vol. 80, no. supp 16, Abstract 6466, pp. 6466. https://doi.org/10.1158/1538-7445.AM2020-6466

Serum immunoglobulins are an independent prognostic marker of time to first therapy in newly diagnosed chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL). / Parikh, Sameer A; Allmer, Cristine; Kleinstern, Geffen et al.
In: Cancer Research, Vol. 80, No. supp 16, Abstract 6466, 2020, p. 6466.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Serum immunoglobulins are an independent prognostic marker of time to first therapy in newly diagnosed chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL)

AU - Parikh, Sameer A

AU - Allmer, Cristine

AU - Kleinstern, Geffen

AU - Boddicker, Nicholas J

AU - Tian, Shulan

AU - De Campos, Cecilia B

AU - Bruins, Laura A

AU - Kabat, Brian F

AU - Rabe, Kari G

AU - Norman, Aaron D

PY - 2020

Y1 - 2020

U2 - 10.1158/1538-7445.AM2020-6466

DO - 10.1158/1538-7445.AM2020-6466

M3 - Meeting Abstract

SN - 0008-5472

VL - 80

SP - 6466

JO - Cancer Research

JF - Cancer Research

IS - supp 16

M1 - Abstract 6466

T2 - AACR Annual Meeting

Y2 - 27 April 2020 through 24 June 2020

ER -